DAVID CUMMINGS: Open Payments
NPI 1386719078 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$537 in 26 payments from 7 companies in 2025. Trend: 2023 $272 · 2024 $801 · 2025 $537
Food & beverage: $537
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $133 |
| Novo Nordisk Inc | 5 | $115 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $109 |
| AstraZeneca Pharmaceuticals LP | 6 | $107 |
| Boston Scientific Corporation | 1 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| PFIZER INC. | 1 | $15 |
Products named: Wegovy, LifeVest, FARXIGA, Repatha, WaveWriter Alpha Prime 16, JARDIANCE, ELIQUIS.
Industry payments across NC — which companies pay providers there.
